Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × High Grade Cervical Intraepithelial Neoplasia × Vaccines × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1 Prostatic Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Medulloblastoma 1 High Grade Cervical Intraepithelial Neoplasia 1 Glioma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms, Male 1 Breast Neoplasms 1

Interventions

Vaccines, DNA 1 Vaccines 1 Biological Products 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02529930 2022-07-13

An Exploratory Safety and Immunogenicity Study of HPV16+ Immunotherapy VB10.16 in Women With HSIL; CIN 2/3)

Nykode Therapeutics ASA

Phase 1/2 Completed

High Grade Cervical Intraepithelial Neoplasia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡